{"id":"https://openalex.org/W2002107673","doi":"https://doi.org/10.1016/j.juro.2010.02.880","title":"1296 RATIONALLY DESIGNED PEPTIDOMIMETICS TARGET ANDROGEN RECEPTOR SIGNALING IN PROSTATE CANCER","display_name":"1296 RATIONALLY DESIGNED PEPTIDOMIMETICS TARGET ANDROGEN RECEPTOR SIGNALING IN PROSTATE CANCER","publication_year":2010,"publication_date":"2010-03-23","ids":{"openalex":"https://openalex.org/W2002107673","doi":"https://doi.org/10.1016/j.juro.2010.02.880","mag":"2002107673"},"language":"en","primary_location":{"id":"doi:10.1016/j.juro.2010.02.880","doi":"https://doi.org/10.1016/j.juro.2010.02.880","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.juro.2010.02.880","pdf_url":null,"source":{"id":"https://openalex.org/S30525748","display_name":"The Journal of Urology","issn_l":"0022-5347","issn":["0022-5347","1527-3792"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Urology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089580275","display_name":"Preethi Ravidnranathan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Preethi Ravidnranathan","raw_affiliation_strings":["Dallas, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dallas, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053069471","display_name":"Ganesh V. Raj","orcid":"https://orcid.org/0000-0001-5098-6347","observed_orcids":["https://orcid.org/0000-0001-5098-6347"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ganesh Raj","raw_affiliation_strings":["Dallas, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dallas, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101896989","display_name":"Lin Yang","orcid":"https://orcid.org/0000-0001-5379-6821","observed_orcids":["https://orcid.org/0000-0001-5379-6821"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lin Yang","raw_affiliation_strings":["Dallas, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dallas, TX","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5081196478","display_name":"Jung\u2010Mo Ahn","orcid":"https://orcid.org/0000-0002-9104-525X","observed_orcids":["https://orcid.org/0000-0002-9104-525X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jung-Mo Ahn","raw_affiliation_strings":["Dallas, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dallas, TX","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.14393539,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"183","issue":"4S","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.7730000019073486},{"id":"https://openalex.org/keywords/androgen-receptor-signaling","display_name":"androgen receptor signaling","score":0.9599999785423279},{"id":"https://openalex.org/keywords/peptidomimetics","display_name":"peptidomimetics","score":0.9179999828338623},{"id":"https://openalex.org/keywords/androgen-receptor-nuclear-translocation","display_name":"androgen receptor nuclear translocation","score":0.6980000138282776},{"id":"https://openalex.org/keywords/lxxll-motif","display_name":"LXXLL motif","score":0.8489999771118164},{"id":"https://openalex.org/keywords/missing-not-at-random","display_name":"missing not at random","score":0.5099999904632568},{"id":"https://openalex.org/keywords/androgen-receptor-antagonists","display_name":"androgen receptor antagonists","score":0.453000009059906},{"id":"https://openalex.org/keywords/androgen-receptor-transcriptional-activity","display_name":"androgen receptor transcriptional activity","score":0.42100000381469727},{"id":"https://openalex.org/keywords/cell-proliferation-inhibition","display_name":"cell proliferation inhibition","score":0.4880000054836273},{"id":"https://openalex.org/keywords/non-genomic-signaling","display_name":"non-genomic signaling","score":0.47200000286102295},{"id":"https://openalex.org/keywords/genomic-signaling","display_name":"genomic signaling","score":0.328000009059906}],"concepts":[{"id":"https://openalex.org/C124790011","wikidata":"https://www.wikidata.org/wiki/Q2069797","display_name":"Peptidomimetic","level":3,"score":0.8599307537078857},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.7900331020355225},{"id":"https://openalex.org/C61367390","wikidata":"https://www.wikidata.org/wiki/Q416601","display_name":"Androgen receptor","level":4,"score":0.7815415859222412},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6142683625221252},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6040488481521606},{"id":"https://openalex.org/C2777911890","wikidata":"https://www.wikidata.org/wiki/Q62614","display_name":"Androgen","level":3,"score":0.5224986672401428},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.4806591272354126},{"id":"https://openalex.org/C63932345","wikidata":"https://www.wikidata.org/wiki/Q422500","display_name":"Nuclear receptor","level":4,"score":0.4330367147922516},{"id":"https://openalex.org/C555283112","wikidata":"https://www.wikidata.org/wiki/Q1637543","display_name":"Carcinogenesis","level":3,"score":0.4199884831905365},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.34312957525253296},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32944250106811523},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.28902608156204224},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.22350695729255676},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.21812286972999573},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.1772538721561432},{"id":"https://openalex.org/C86339819","wikidata":"https://www.wikidata.org/wiki/Q407384","display_name":"Transcription factor","level":3,"score":0.11051791906356812},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.07181483507156372},{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.juro.2010.02.880","doi":"https://doi.org/10.1016/j.juro.2010.02.880","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.juro.2010.02.880","pdf_url":null,"source":{"id":"https://openalex.org/S30525748","display_name":"The Journal of Urology","issn_l":"0022-5347","issn":["0022-5347","1527-3792"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Urology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8999999761581421,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.6399999856948853,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1966774524","https://openalex.org/W2165177861","https://openalex.org/W2331261629","https://openalex.org/W2063298728","https://openalex.org/W1552722454","https://openalex.org/W2068178289","https://openalex.org/W1974552878","https://openalex.org/W2615341504","https://openalex.org/W2319265286","https://openalex.org/W1991351559"],"abstract_inverted_index":{"You":[0],"have":[1,119,177,267,404],"accessJournal":[2],"of":[3,96,156,279,288,293,337,356,392,410,416,427,435],"UrologyProstate":[4],"Cancer:":[5],"Basic":[6],"Research":[7],"VII1":[8],"Apr":[9],"20101296":[10],"RATIONALLY":[11],"DESIGNED":[12],"PEPTIDOMIMETICS":[13],"TARGET":[14],"ANDROGEN":[15],"RECEPTOR":[16],"SIGNALING":[17],"IN":[18],"PROSTATE":[19],"CANCER":[20],"Preethi":[21,30,495],"Ravidnranathan,":[22],"Ganesh":[23,39,502],"Raj,":[24],"Lin":[25,48,509],"Yang,":[26],"and":[27,57,91,104,107,135,147,161,207,227,254,295,299,317,373,473,491],"Jung-Mo":[28,58,516],"Ahn":[29,60,517],"RavidnranathanPreethi":[31],"Ravidnranathan":[32,496],"More":[33,42,51,61,497,504,511,518],"articles":[34,43,52,62,498,505,512,519],"by":[35,44,53,63,110,285,468,486,499,506,513,520],"this":[36,45,54,64,406,447,500,507,514,521],"author":[37,46,55,65,501,508,515,522],",":[38,47,56],"RajGanesh":[40],"Raj":[41,503],"YangLin":[49],"Yang":[50,510],"AhnJung-Mo":[59],"View":[66],"All":[67,524],"Author":[68],"Informationhttps://doi.org/10.1016/j.juro.2010.02.880AboutPDF":[69],"ToolsAdd":[70],"to":[71,145,187,196,221,234,239,259,263,290,306,333,358,394,398],"favoritesDownload":[72],"CitationsTrack":[73],"CitationsPermissionsReprints":[74],"ShareFacebookTwitterLinked":[75],"InEmail":[76],"INTRODUCTION":[77],"AND":[78],"OBJECTIVES":[79],"Androgen":[80],"receptor":[81],"(AR)":[82],"signaling":[83,99,171,421],"is":[84,108,137,194,408],"essential":[85],"for":[86,139,229,456],"prostate":[87,173,428,463],"cancer":[88,213,429],"development,":[89],"growth,":[90],"progression":[92],"at":[93],"all":[94,365],"stages":[95],"disease.":[97],"AR":[98,111,136,140,160,169,237,294,381,393,418,439,458],"occurs":[100],"via":[101],"both":[102,252,312],"genomic":[103,150,170,420,440],"non-genomic":[105],"pathways":[106],"mediated":[109,419],"interaction":[112,123,158,437],"with":[113,218,223,462],"cofactors.":[114],"In":[115],"our":[116],"laboratory,":[117],"we":[118,384],"shown":[120,268,405],"that":[121,154,193,269,386,446],"the":[122,157,188,240,260,273,277,280,286,322,346,387,395,399],"between":[124,159],"a":[125,208,452],"cofactor,":[126],"PELP-1":[127,162,296],"(Proline,":[128],"Glutamic":[129],"acid,":[130],"Leucine":[131],"rich":[132],"Protein":[133],"1)":[134],"critical":[138],"nuclear":[141,414],"translocation":[142,238,391,415],"in":[143,172,297,340,342,364,431,460],"response":[144],"ligand":[146],"subsequent":[148],"AR-mediated":[149],"signaling.":[151,441],"We":[152,176,266,403],"hypothesized":[153],"disruption":[155],"using":[163,247],"rationally":[164,179],"designed":[165,180],"peptidomimetics":[166,185,201,219],"could":[167],"affect":[168],"cancer.":[174,464],"METHODS":[175],"developed":[178],"bis":[181],"benzamide":[182],"scaffold-based":[183],"\u03b1-helical":[184],"analogous":[186],"LXXLL":[189,209],"motif":[190],"on":[191],"MNAR":[192],"presumed":[195],"bind":[197],"AR.":[198],"Initially":[199],"two":[200],"were":[202,216,256],"created":[203],"\u00a1V":[204],"control":[205,274,323,347,400],"D1":[206,253,324,348],"analogue":[210],"D2.":[211],"Prostate":[212],"cell":[214,301],"lines":[215],"pre-treated":[217],"prior":[220],"incubation":[222],"androgen":[224],"(DHT/R1881":[225],"(0.01-10nM))":[226],"evaluated":[228],"proliferation.":[230],"Immunofluorescence":[231],"was":[232,304,331,362],"used":[233],"examine":[235],"endogenous":[236],"DAPI-stained":[241],"nucleus.":[242],"RESULTS":[243],"Initial":[244],"toxicity":[245],"assays":[246],"trypan":[248],"blue":[249],"exclusion":[250],"revealed":[251],"D2":[255,270,289,303,330,357,389],"not":[257,272,326,350,376],"toxic":[258],"cells":[261,339,368,378,430],"up":[262],"500nM":[264],"concentrations.":[265],"(but":[271],"D1)":[275],"prevents":[276],"formation":[278],"AR-PELP-1":[281,412],"complex":[282],"as":[283,422,424,451],"evidenced":[284],"ability":[287,355],"prevent":[291],"co-immunoprecipitation":[292],"LaPC4":[298],"LnCaP":[300],"lines.":[302],"able":[305,332],"significantly":[307],"decrease":[308],"DHT-mediated":[309,335,360,425],"transcription":[310],"from":[311],"minimal":[313],"ARE":[314],"luciferase":[315],"promoters":[316],"PSA":[318],"gene":[319],"expression,":[320],"whereas":[321,345],"did":[325,349],"show":[327,351],"any":[328,352],"activity.":[329,353],"reduce":[334],"proliferation":[336,361,426],"PCa":[338,367],"vitro":[341],"dose-dependent":[343],"manner,":[344],"This":[354],"inhibit":[359],"noted":[363,385],"androgen-responsive":[366],"LAPC4,":[369],"LnCaP,":[370],"RWPE1,":[371],"C4-2":[372],"CWR22v1,":[374],"but":[375],"PC-3":[377],"which":[379],"lack":[380],"expression.":[382],"Interestingly,":[383],"peptidomimetic":[388,407],"blocked":[390],"nucleus":[396],"compared":[397],"D1.":[401],"CONCLUSIONS":[402],"capable":[409],"blocking":[411],"interaction,":[413],"AR,":[417],"well":[423],"vitro.":[432],"Selective":[433],"targeting":[434],"PELP-1-AR":[436],"affects":[438],"These":[442],"data":[443],"strongly":[444],"indicate":[445],"strategy":[448],"may":[449],"serve":[450],"viable":[453],"therapeutic":[454],"target":[455],"disrupting":[457],"function":[459],"patients":[461],"Dallas,":[465],"TX\u00a9":[466],"2010":[467,485],"American":[469,487],"Urological":[470,488],"Association":[471,489],"Education":[472,490],"Research,":[474,492],"Inc.FiguresReferencesRelatedDetails":[475],"Volume":[476],"183Issue":[477],"4SApril":[478],"2010Page:":[479],"e501-e502":[480],"Advertisement":[481,525,526],"Copyright":[482],"&":[483],"Permissions\u00a9":[484],"Inc.MetricsAuthor":[493],"Information":[494],"Expand":[523],"PDF":[527],"downloadLoading":[528],"...":[529]},"counts_by_year":[],"updated_date":"2025-11-06T03:46:38.306776","created_date":"2016-06-24T00:00:00"}